Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Margarita Alonso

Psychiatry Poway, CA Medical Doctor

NPI 1780618082 CMS profile 755720

15525 Pomerado Rd, Poway, CA 92064

Open in the dashboard

General payments

$1,592

103 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Margarita Alonso of Poway, CA is reported in the CMS Open Payments database as having received $1,592 across 103 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $120 1
2023 General $28 1
2021 General $39 2
2020 General $336 18
2019 General $1,070 81

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Margarita Alonso
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Margarita Alonso were reported at $120. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Margarita Alonso Psychiatry median Middle half National median
2019 $1,070 $184 $59–$605 $163
2020 $336 $119 $36–$372 $114
2021 $39 $143 $43–$576 $132
2022 $0 $153 $50–$590 $149
2023 $28 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $120 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sunovion Pharmaceuticals Inc. $304 23 payments
  2. Lundbeck LLC $285 21 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $220 11 payments
  4. Janssen Pharmaceuticals, Inc $180 10 payments
  5. AstraZeneca Pharmaceuticals LP $120 1 payment
  6. Allergan Inc. $118 17 payments
  7. Otsuka America Pharmaceutical, Inc. $95 6 payments
  8. Vanda Pharmaceuticals Inc. $64 3 payments
  9. Vertical Pharmaceuticals, LLC $55 3 payments
  10. Ironshore Pharmaceuticals Inc. $54 3 payments
  11. Other $96 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,592 103 payments
Products named General payments · program years 2019–2025
  1. LATUDA $304 23 payments
  2. REXULTI Psychiatry $178 13 payments
  3. SPRAVATO $122 8 payments
  4. FASENRA $120 1 payment
  5. VRAYLAR $118 17 payments
  6. BRINTELLIX $107 8 payments
  7. INVEGA SUSTENNA $106 5 payments
  8. INVEGA TRINZA $106 5 payments
  9. REXULTI Psychiatry $95 6 payments
  10. Trintellix $72 4 payments
  11. Other $461 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

433

Median for Psychiatry: 574

Drug cost

$38,367

Median for Psychiatry: $27,624

Branded share of claims

23.8%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Trintellix Vortioxetine Hydrobromide Brand 18 $26,246
Vyvanse Lisdexamfetamine Dimesylate Brand 12 $4,580
Duloxetine Hcl Generic 58 $2,400
Bupropion Xl Bupropion Hcl Brand 44 $1,201
Venlafaxine Hcl Er Venlafaxine Hcl Brand 29 $1,033
Escitalopram Oxalate Generic 37 $670
Methylphenidate Hcl Generic 19 $504
Lamotrigine Generic 29 $453
Gabapentin Generic 32 $400
Fluoxetine Hcl Generic 13 $210

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$22,555

Medicare's payments for the services billed

Medicare patients

33

Average age 73

Services billed

324

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 64%
Arthritis 55%
High blood pressure 48%
Osteoporosis 36%
Heart failure 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

103 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record